[The home care nurse, a resource to help combat intrafamily violence].

Every year in France, thousands of victims file a complaint for violence against their partner. These acts of violence are committed in the family environment, behind closed doors. Through her practice, the home care nurse can be a witness, support or a resource.

Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.

Purpose: This study examines the role of (18)F-labeled fluorodeoxyglucose positron emission tomography (FDG-PET) in the implementation of involved-node radiation therapy (INRT) in patients treated for clinical stages (CS) I/II supradiaphragmatic Hodgkin lymphoma (HL).

Methods And Material: Patients with untreated CS I/II HL enrolled in the randomized EORTC/LYSA/FIL Intergroup H10 trial and participating in a real-time prospective quality assurance program were prospectively included in this study. Data were electronically obtained from 18 French cancer centers.

[An integrated medical image network of patient records: experience of the Picture Archiving and Communication System (PACS) of the Gustave-Roussy Institute].

The PACS (Picture Archiving and Communication System) is a central radiologic image archiving system coupled with an information system which allows rapid access to these images. It permits rapid access of the entire file of radiologic images of a patient for radiologists and clinicians. After installation of an MRI and CT scan unit at the IGR, a PACS system was installed in July, 2000.

Epstein-Barr virus serology in bone marrow transplantations: a one-year retrospective study with detection of EBV IgM-VCA-specific antibodies.

The specific antibody response to Epstein-Barr virus (EBV) antigens of 41 bone marrow transplant recipients with leukemia or aplastic anemia was examined retrospectively by immunofluorescence test (IF) over 1 year. We observed high titers (greater than 640) of IgG-viral capsid antigen (VCA) with emergence of IgG-early antigen (EA) and frequent absence or low levels of Epstein-Barr nuclear antigen (EBNA) antibodies. After absorption to remove rheumatoid factor (RF), five of the 41 recipients had IgM-VCA antibody to EBV, which appeared between weeks 26 and 48 after BMT and persisted for 1-4 months.